1
|
Khan I, Kaempf A, Raghuwanshi S, Chesnokov M, Zhang X, Wang Z, Domling A, Tyner JW, Camacho C, Gartel AL. Favorable outcomes of NPM1 mut AML patients are due to transcriptional inactivation of FOXM1, presenting a new target to overcome chemoresistance. Blood Cancer J 2023; 13:128. [PMID: 37607920 PMCID: PMC10444844 DOI: 10.1038/s41408-023-00898-4] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2023] [Revised: 07/21/2023] [Accepted: 08/01/2023] [Indexed: 08/24/2023] Open
Affiliation(s)
- I Khan
- University of Illinois at Chicago, Department of Medicine, Chicago, IL, USA
- Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA
| | - A Kaempf
- OHSU Knight Cancer Institute, School of Medicine, Portland, OR, USA
| | - S Raghuwanshi
- University of Illinois at Chicago, Department of Medicine, Chicago, IL, USA
| | - M Chesnokov
- Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain
| | - X Zhang
- University of Illinois at Chicago, Department of Medicine, Chicago, IL, USA
| | - Z Wang
- The Czech Advanced Technology and Research Institute (CATRIN) of Palacký University, Olomouc, Czech Republic
- University of Groningen, Groningen, Netherlands
| | - A Domling
- The Czech Advanced Technology and Research Institute (CATRIN) of Palacký University, Olomouc, Czech Republic
| | - J W Tyner
- OHSU Knight Cancer Institute, School of Medicine, Portland, OR, USA
| | - C Camacho
- Computational and Systems Biology, University of Pittsburgh, Pittsburgh, PA, USA
| | - A L Gartel
- University of Illinois at Chicago, Department of Medicine, Chicago, IL, USA.
| |
Collapse
|